John Coombs - Concepedia

Author

John Coombs

Novartis (United States)

Also Known As

J Coombs, J H Coombs, J. COOMBS, J. Coombs, J.H Coombs, John Coombs, John H Coombs, John H. Coombs

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Novartis (United States)Pfizer (United States)RTI Health Solutions Dana-Farber Cancer Institute Inserm

About

John Coombs is an author at Novartis (United States) specializing in medicine, health policy, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	280
2	Public Health	3	3	99
3	Health Policy	3	3	99
4	Family Medicine	1	1	20
5	Pathology	1	1	42

John Coombs

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double‐blind, placebo‐controlled phase IIa trial of three dosage levels of CP‐690,550 versus placebo Joel M. Kremer, Bradley J. Bloom, Ferdinand C. Breedveld, Arthritis & Rheumatism	2009	541
Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690,550, an orally active Janus kinase (JAK) inhibitor: results from a randomised, double-blind, placebo-controlled trial John Coombs, Bradley J. Bloom, F. C. Breedveld, Annals of the Rheumatic Diseases	2009	147
Healthcare resource utilization and costs associated with non-adherence to imatinib treatment in chronic myeloid leukemia patients Eric Q. Wu, Scott J. Johnson, Nicolas Beaulieu, Current Medical Research and Opinion	2009	129
Compliance from Self-Reported versus Pharmacy Claims Data with Metered-Dose Inhalers Steven R. Erickson, John Coombs, Duane M. Kirking, Annals of Pharmacotherapy	2001	116
Celecoxib is efficacious and well tolerated in treating signs and symptoms of ankylosing spondylitis. André Barkhuizen, Serge Steinfeld, Jeffery Robbins, PubMed	2006	75
Development of the Cancer Therapy Satisfaction Questionnaire: Item Generation and Content Validity Testing Linda Abetz, John Coombs, Dorothy L. Keininger, Value in Health Content Validity TestingQuality Of LifeMedicineItem Response TheoryPatient-reported Outcome	2005	72
Stated Preferences of Patients with Cancer for Health-related Quality-of-life (HRQOL) Domains During Treatment David Osoba, Ming‐Ann Hsu, Catherine Copley‐Merriman, Quality of Life Research Quality Of LifeLife AssessmentHealth PolicyMedicineCancer Management	2006	68
Early Onset of Oral Cancer among Women who Drink and Smoke Irwin D. J. Bross, John Coombs Oncology	1976	67
Epidemiology, survival, and costs of localized gastrointestinal stromal tumors Sanon, Sanon, Douglas C.A. Taylor, International Journal of General Medicine	2011	50
Are Chemotherapy Patients’ HRQoL Importance Weights Consistent with Linear Scoring Rules? A Stated-choice Approach F. Reed Johnson, Brett Hauber, David Osoba, Quality of Life Research Stated-choice ApproachMedicinePatient-reported OutcomePharmacotherapyMedical Decision Analysis	2006	47

Page 1